Inflammasominhibitoren
At a glance
- Project leader : Prof. Dr. Rainer Riedl
- Project team : Dr. Stefano Agnello
- Project budget : CHF 477'000
- Project status : completed
- Funding partner : Innosuisse (Innovationsprojekt / Projekt Nr. 38802.1 IP-LS)
- Project partner : Universität Basel / Biozentrum, Université de Lausanne
- Contact person : Rainer Riedl
Description
Inhibition of the Inflammasome is a promising strategy to fight certain diseases with an (auto-)immune component, including gout, arthritis, Alzheimer's and Parkinson's. We will develop, optimize and validate one or several new Inflammasome inhibitors, starting from an existing set of lead molecules.